1. Home
  2. ENRD vs AURA Comparison

ENRD vs AURA Comparison

Compare ENRD & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Einride AB American Depositary Shares

ENRD

Einride AB American Depositary Shares

HOLD

Current Price

$2.50

Market Cap

560.3M

Sector

Technology

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

SELL

Current Price

$6.12

Market Cap

631.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ENRD
AURA
Founded
2016
2007
Country
Sweden
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
631.6M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ENRD
AURA
Price
$2.50
$6.12
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $16.60
AVG Volume (30 Days)
194.0K
★ 990.6K
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$40.92
N/A
Revenue Next Year
$205.35
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.66
$4.73
52 Week High
$10.49
$9.54

Technical Indicators

Market Signals
Indicator
ENRD
AURA
Relative Strength Index (RSI) 23.95 38.49
Support Level N/A $6.03
Resistance Level $4.38 $6.24
Average True Range (ATR) 0.32 0.25
MACD -0.05 0.05
Stochastic Oscillator 3.48 19.86

Price Performance

Historical Comparison
ENRD
AURA

About ENRD Einride AB American Depositary Shares

Einride AB is a technology company that develops and operates digital, electric, and autonomous freight solutions. Its platform includes planning and optimization tools, autonomous technologies, electric heavy-duty vehicle fleets, and charging infrastructure. It serves customers across North America, Europe, and the Middle East. The company's solutions support customers in transitioning logistics operations to electric and autonomous systems. Its business model includes Freight-Capacity-as-a-Service (FCaaS) and Software-as-a-Service (SaaS) offerings delivered through an AI-based platform that manages aspects of electric and autonomous operations.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: